| Setting international standards in analyzing patient-reported outcomes and quality of life endpoints in cancer clinical trials-innovative medicines initiative (SISAQOL-IMI … M Pe, A Alanya, RS Falk, CD Amdal, K Bjordal, J Chang, P Cislo, ... The Lancet Oncology 24 (6), e270-e283, 2023 | 26 | 2023 |
| EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals MJ Pilz, EM Gamper, F Efficace, JI Arraras, S Nolte, G Liegl, M Rose, ... BMC Public Health 22 (1), 1040, 2022 | 21 | 2022 |
| Evaluating the thresholds for clinical importance of the EORTC QLQ-C15-PAL in patients receiving palliative treatment MJ Pilz, NK Aaronson, JI Arraras, G Caocci, F Efficace, M Groenvold, ... Journal of palliative medicine 24 (3), 397-404, 2021 | 19 | 2021 |
| Patient‐reported outcome measures for emotional functioning in cancer patients: Content comparison of the EORTC CAT Core, FACT‐G, HADS, SF‐36, PRO‐CTCAE, and PROMIS instruments M Rothmund, MJ Pilz, N Egeter, E Lidington, C Piccinin, JI Arraras, ... Psycho‐Oncology 32 (4), 628-639, 2023 | 10 | 2023 |
| The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands MJ Pilz, S Seyringer, LR Hallsson, A Bottomley, F Jansen, MT King, ... The European Journal of Health Economics 25 (9), 1539-1555, 2024 | 6 | 2024 |
| Content comparison of the EORTC CAT Core, SF‐36, FACT‐G, and PROMIS role and social functioning measures based on the International Classification of Functioning, Disability … MJ Pilz, M Rothmund, E Lidington, C Piccinin, JI Arraras, M Groenvold, ... Psycho‐Oncology 32 (9), 1372-1384, 2023 | 5 | 2023 |
| Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients—Data from Four Multicentre LUX-Lung Trials, Applying … MJ Pilz, S Seyringer, I Al-Naesan, MT King, A Bottomley, R Norman, ... PharmacoEconomics-Open, 1-14, 2024 | 4 | 2024 |
| General population normative data from seven European countries for the K10 and K6 scales for psychological distress J Lehmann, MJ Pilz, B Holzner, G Kemmler, JM Giesinger Scientific Reports 13 (1), 18389, 2023 | 4 | 2023 |
| The European organisation for research and treatment of cancer quality of life utility-core 10 dimensions: development and investigation of general population utility norms for … MJ Pilz, S Nolte, G Liegl, M King, R Norman, H McTaggart-Cowan, ... Value in Health 26 (5), 760-767, 2023 | 4 | 2023 |
| Equipercentile equating of scores from common patient-reported outcome measures of physical function in patients with cancer M Rothmund, MJ Pilz, L Schlosser, JI Arraras, M Groenvold, B Holzner, ... Journal of Clinical Epidemiology 165, 111203, 2024 | 3 | 2024 |
| The EORTC QLU-C10D-development and investigation of general population utility norms for Canada, France, Germany, Italy, Poland and the UK MJ Pilz, S Nolte, G Liegl, M King, R Norman, H McTaggart-Cowan, ... Value in Health: the Journal of the International Society for …, 2022 | 2 | 2022 |
| Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma S Seyringer, MJ Pilz, A Bottomley, MT King, R Norman, EM Gamper, ... The European Journal of Health Economics, 1-13, 2024 | 1 | 2024 |
| The cancer-specific health economic measure QLU-C10D is valid and responsive for assessing health utility in patients with thyroid cancer MJ Pilz, S Seyringer, S Singer, G Ioannidis, GP Sykiotis, JI Arraras, ... Thyroid 34 (11), 1356-1370, 2024 | 1 | 2024 |
| General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population MJ Pilz, FLC Loth, S Nolte, AMM Thurner, EM Gamper, A Anota, G Liegl, ... Journal of Patient-Reported Outcomes 8 (1), 48, 2024 | 1 | 2024 |
| Clinical Validity of the Cancer-Specific Utility Measure EORTC QLU-C10D: Retrospective Analyses of Four Lung Cancer Trials Using Six Country Tariffs. S Seyringer, M Pilz, I Al-Naesan, M King, A Bottomley, R Norman, ... | 1 | 2024 |
| Cancer-Specific Utility Instrument for Health Economic Evaluations: A Synopsis of the EORTC QLU-C10D User Manual and Current Validity Evidence S Seyringer, M Pilz, F Jansen, M Büttner, MT King, R Norman, G Kemmler, ... European Journal of Cancer, 115235, 2025 | | 2025 |
| PCR98 Establishing Thresholds for Clinical Importance for EORTC Questionnaire Modules for Eight Specific Groups of Cancer Patients MJ Pilz, AMM Thurner, A Belancic, JI Arraras, R Bultijnck, K De Ligt, ... Value in Health 27 (12), S524, 2024 | | 2024 |
| Comparing the contents of patient-reported outcome measures for fatigue: EORTC CAT Core, EORTC QLQ-C30, EORTC QLQ-FA12, FACIT, PRO-CTCAE, PROMIS, Brief Fatigue Inventory … M Rothmund, MJ Pilz, N Egeter, E Lidington, C Piccinin, JI Arraras, ... Health and Quality of Life Outcomes 22 (1), 1-10, 2024 | | 2024 |
| Norwegian and Swedish value sets for the EORTC QLU-C10D utility instrument G Rohde, J Lehmann, MJ Pilz, L Rojas-Concha, B Holzner, MT King, ... Quality of Life Research, 1-15, 2024 | | 2024 |
| Establishing thresholds for clinical importance for EORTC questionnaire modules for specific cancer patient populations MJ Pilz, JI Arraras, A Bottomley, F Efficace, M Groenvold, B Holzner, ... QUALITY OF LIFE RESEARCH 31, S49-S49, 2022 | | 2022 |
